(Q61975440)
Statements
A Multicenter Randomized, Double-blind, Placebo and Positive Controlled ,Parallel Group ,Phase II Study to Access the Efficacy and Safety of SP2086 Treated Type 2 Diabetes Patients (English)
0 references
June 2011
0 references
April 2012
0 references
200
0 references
20 year
0 references
70 year
0 references